---
figid: PMC9654040__cancers-14-05196-g002
figtitle: Whole New Comprehension about ncRNA-Encoded Peptides/Proteins in Cancers
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9654040
filename: cancers-14-05196-g002.jpg
figlink: /pmc/articles/PMC9654040/figure/cancers-14-05196-f002/
number: F2
caption: NcRNA-encoded peptides/proteins regulated signal transduction. (a) β-Catenin-370aa
  and AXIN1-295aa competitively bound to component(GSK-3β, APC) in destruction complex
  to activate Wnt/β-catenin pathway, promoting proliferation and metastasis in HCC
  and GC. (b) CIP2A-BP competitively bound to CIP2A, prohibiting p-AKT and TNBC metastasis;
  HER2-103 induced EGFR/HER3 homo/heterodimer formation and downregulated PI3K/AKT
  activation, promoting proliferation and invasion in TNBC; AKT3-174aa combine with
  PDK1 to stimulate p-AKT activation, prohibiting proliferation in GBM. (c) MAPK1-109aa
  and SMIM30 interacted with MEK1, SRC/YES1 to regulate MAPK signaling, influencing
  proliferation and metastasis in GC and HCC; ASK1-272aa competitively boundto AKT1
  to activate ASK1/JNK/p38 signaling, promoting apoptosis in LAUD.
papertitle: A Whole New Comprehension about ncRNA-Encoded Peptides/Proteins in Cancers.
reftext: Qinnan Chen, et al. Cancers (Basel). 2022 Nov;14(21):5196.
year: '2022'
doi: 10.3390/cancers14215196
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: peptides/proteins encoded by ncRNAs | translation mechanism | cancers |
  clinical applications
automl_pathway: 0.9159311
figid_alias: PMC9654040__F2
figtype: Figure
redirect_from: /figures/PMC9654040__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9654040__cancers-14-05196-g002.html
  '@type': Dataset
  description: NcRNA-encoded peptides/proteins regulated signal transduction. (a)
    β-Catenin-370aa and AXIN1-295aa competitively bound to component(GSK-3β, APC)
    in destruction complex to activate Wnt/β-catenin pathway, promoting proliferation
    and metastasis in HCC and GC. (b) CIP2A-BP competitively bound to CIP2A, prohibiting
    p-AKT and TNBC metastasis; HER2-103 induced EGFR/HER3 homo/heterodimer formation
    and downregulated PI3K/AKT activation, promoting proliferation and invasion in
    TNBC; AKT3-174aa combine with PDK1 to stimulate p-AKT activation, prohibiting
    proliferation in GBM. (c) MAPK1-109aa and SMIM30 interacted with MEK1, SRC/YES1
    to regulate MAPK signaling, influencing proliferation and metastasis in GC and
    HCC; ASK1-272aa competitively boundto AKT1 to activate ASK1/JNK/p38 signaling,
    promoting apoptosis in LAUD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - HCC
  - HYCC1
  - GSK3B
  - GC
  - APC
  - PROC
  - LINC00665
  - PTPA
  - CIP2A
  - AKT1
  - AKT2
  - AKT3
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP2K1
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP3K5
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
---
